Portal de Periódicos da CAPES

Danaparoid is effective and safe for patients with obstetric antiphospholipid syndrome

2019; Oxford University Press; Volume: 30; Issue: 2 Linguagem: Inglês

10.1080/14397595.2019.1602241

1439-7609

Hiroyuki Yoshihara, Mayumi Sugiura‐Ogasawara, Tamao Kitaori, Kinue Katano, Yasuhiko Ozaki,

Platelet Disorders and Treatments

Journal Article Danaparoid is effective and safe for patients with obstetric antiphospholipid syndrome Get access Hiroyuki Yoshihara, Hiroyuki Yoshihara Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan; Search for other works by this author on: Oxford Academic Google Scholar Mayumi Sugiura-Ogasawara, Mayumi Sugiura-Ogasawara Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan; CONTACT Mayumi Sugiura-Ogasawara og.mym@med.nagoya-cu.ac.jp Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical Sciences, Mizuho-ku, Nagoya 4678601, Japan Search for other works by this author on: Oxford Academic Google Scholar Tamao Kitaori, Tamao Kitaori Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan; Search for other works by this author on: Oxford Academic Google Scholar Kinue Katano, Kinue Katano Obstetrics & Gynecology Katano Clinic, Kasugai, Japan Search for other works by this author on: Oxford Academic Google Scholar Yasuhiko Ozaki Yasuhiko Ozaki Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan; Search for other works by this author on: Oxford Academic Google Scholar Modern Rheumatology, Volume 30, Issue 2, 3 March 2020, Pages 332–337, https://doi.org/10.1080/14397595.2019.1602241 Published: 03 March 2020 Article history Received: 14 November 2018 Accepted: 25 March 2019 Published: 03 March 2020